No abstract available
MeSH terms
-
Adenocarcinoma / diagnosis*
-
Adenocarcinoma / drug therapy*
-
Adenocarcinoma / mortality
-
Adenocarcinoma / pathology
-
Aged
-
Antineoplastic Agents / adverse effects
-
Antineoplastic Agents / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Cell Transformation, Neoplastic / genetics
-
Cell Transformation, Neoplastic / pathology
-
Combined Modality Therapy
-
Cooperative Behavior*
-
Disease-Free Survival
-
Early Diagnosis
-
ErbB Receptors / antagonists & inhibitors
-
ErbB Receptors / genetics
-
Humans
-
Interdisciplinary Communication*
-
Lung Neoplasms / diagnosis*
-
Lung Neoplasms / drug therapy*
-
Lung Neoplasms / mortality
-
Lung Neoplasms / pathology
-
Neoplasm Staging
-
Palliative Care
-
Practice Guidelines as Topic
-
Precision Medicine
-
Prognosis
-
Tomography, X-Ray Computed
Substances
-
Antineoplastic Agents
-
EGFR protein, human
-
ErbB Receptors